2022 | Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| DIAGNOSTICS |
2022 | Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2022 | Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2022 | New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2022 | Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study
| JOURNAL OF IMMUNOLOGY RESEARCH |
2022 | Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea
| STROKE AND VASCULAR NEUROLOGY |
2022 | Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
2022 | Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? | RHEUMATOLOGY |
2022 | Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience | LUPUS |
2022 | Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis
| JOURNAL OF CLINICAL MEDICINE |
2022 | Aortic valve surgery in patients with Takayasu's arteritis: a nationwide analysis of 1,197 patients during a 9-year period
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2022 | A retrospective analysis of antineutrophil cytoplasmic antibody-associated vasculitis aiming for an equation prediction end-stage renal disease | CLINICAL RHEUMATOLOGY |
2022 | Clinical application of low erythrocyte sedimentation rate/high C-reactive protein to antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2022 | Serum vitamin D level correlates with disease activity and health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis | ZEITSCHRIFT FUR RHEUMATOLOGIE |
2022 | Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis | RHEUMATOLOGY INTERNATIONAL |
2022 | Drug Survival of Biologic Therapy in Elderly Patients With Rheumatoid Arthritis Compared With Nonelderly Patients: Results From the Korean College of Rheumatology Biologics Registry | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY |
2022 | Association Between Idiopathic Cutaneous Leukocytoclastic Angiitis and ANCA-negative Microscopic Polyangiitis
| Journal of Rheumatic Diseases |
2022 | 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease by Wallace et al | ANNALS OF THE RHEUMATIC DISEASES |
2021 | Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
2021 | Prevalence of Osteopenia in Drug-Naive Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Monocentric Study | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY |
2021 | Serum progranulin as a predictive marker for high activity of antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2021 | Serum Clusterin Level Could Reflect the Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| YONSEI MEDICAL JOURNAL |
2021 | Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE |
2021 | Evaluation of body composition using computed tomography in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2021 | Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL RHEUMATOLOGY |
2021 | Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis
| MEDICINE |
2021 | Novel mortality-predicting index at diagnosis can effectively predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2021 | Systemic inflammation response index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL UROLOGY AND NEPHROLOGY |
2021 | Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2021 | Predictive Ability of Serum IL-27 Level for Assessing Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDIATORS OF INFLAMMATION |
2021 | Fibrosis-5 predicts end-stage renal disease in patients with microscopic polyangiitis and granulomatosis with polyangiitis without substantial liver diseases | CLINICAL AND EXPERIMENTAL MEDICINE |
2021 | Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis
| PLOS ONE |
2021 | The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| YONSEI MEDICAL JOURNAL |
2021 | Male Sex Is a Significant Predictor of All-cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Clinical features of Korean elderly patients with antineutrophil cytoplasmic antibody-associated vasculitis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2021 | Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis | IN VIVO |
2021 | Total Haemolytic Complement Activity at Diagnosis as an Indicator of the Baseline Activity of Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| Journal of Rheumatic Diseases |
2021 | Association between follistatin-related protein 1 and the functional status of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
| CHINESE MEDICAL JOURNAL |
2021 | Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2021 | The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases
| CLINICS |
2021 | Clinical and imaging findings suggestive of histopathological immunoglobulin G4-related disease: a single-center retrospective study | CLINICAL RHEUMATOLOGY |
2021 | Efficacy of the fibrosis index for predicting end-stage renal disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE |
2021 | Serological Biomarkers and Indices for the Current Activity and Prognosis of ANCA-Associated Vasculitis: Experience in a Single Centre in Korea
| YONSEI MEDICAL JOURNAL |
2021 | D-dimer predicts poor hospitalisation outcomes in patients with antineutrophil cytoplasmic autoantibody-associated vasculitis | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2021 | Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2021 | Risk of Stroke in Systemic Necrotizing Vasculitis: A Nationwide Study Using the National Claims Database
| FRONTIERS IN IMMUNOLOGY |
2021 | Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2021 | Serum chitinase-3-like 1 protein is a useful biomarker to assess disease activity in ANCA-associated vasculitis: an observational study
| ARTHRITIS RESEARCH & THERAPY |
2021 | Antineutrophil Cytoplasmic Antibody Positivity Is Associated with Vascular Involvement in Behçet's Disease
| YONSEI MEDICAL JOURNAL |
2021 | Serum granzyme B is associated with otorhinolaryngological; pulmonary; and renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis | JOURNAL OF INVESTIGATIVE MEDICINE |